07:00 , Apr 16, 2012 |  BC Week In Review  |  Company News

Nuron, Vitruvian Biomedical deal

Vitruvian granted Nuron exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine, a DNA vaccine containing a gene fragment that codes for beta amyloid 42. The vaccine is in preclinical development to...
01:08 , Apr 10, 2012 |  BC Extra  |  Company News

Nuron in-licenses preclinical AD vaccine

Vitruvian Biomedical Inc. (Addison, Texas) granted Nuron Biotech Inc. (Exton, Pa.) exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine, a DNA vaccine containing a gene fragment that codes for beta amyloid 42. The...